Tom Hugh
Overview
Explore the profile of Tom Hugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawashima J, Akabane M, Endo Y, Woldesenbet S, Khalil M, Sahara K, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40067612
No abstract available.
2.
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al.
Eur J Surg Oncol
. 2025 Mar;
51(6):109723.
PMID: 40023021
Background: Severe postoperative complications still occur following hepatectomy among patients with hepatocellular carcinoma (HCC). There is a need to identify high-risk patients for severe complications to enhance patient safety. We...
3.
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al.
Eur J Surg Oncol
. 2025 Feb;
51(6):109683.
PMID: 40009916
Background: The association between preoperative imaging and postoperative pathological tumor size disparity, and cancer-specific survival (CSS) among patients undergoing hepatectomy for hepatocellular carcinoma (HCC) remains unclear. We sought to evaluate...
4.
Catalano G, Alaimo L, Chatzipanagiotou O, Rashid Z, Kawashima J, Ruzzenente A, et al.
J Gastrointest Surg
. 2025 Feb;
29(4):101997.
PMID: 39971095
Background: Gallbladder cancer (GBC) is associated with a poor prognosis. Recurrence patterns and their effect on survival remain ill-defined. This study aimed to analyze recurrence patterns and develop a machine...
5.
Altaf A, Akabane M, Khalil M, Rashid Z, Zindani S, Kawashima J, et al.
HPB (Oxford)
. 2025 Feb;
PMID: 39956729
Background: We sought to determine the association between intraoperative blood loss (IBL) and postoperative morbidity among patients undergoing surgery for liver cancer. Methods: Patients undergoing surgery for primary and secondary...
6.
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al.
J Gastrointest Surg
. 2025 Feb;
29(4):101984.
PMID: 39922533
Background: The albumin-bilirubin (ALBI) score, used for predicting outcomes after hepatocellular carcinoma (HCC) resection, does not directly capture liver cell damage or biliary obstruction. Gamma-glutamyl transferase (GGT), which reflects hepatic...
7.
Kawashima J, Akabane M, Endo Y, Woldesenbet S, Khalil M, Sahara K, et al.
Ann Surg Oncol
. 2025 Jan;
PMID: 39888467
Background: The feasibility of trials in liver surgery using a single-component clinical endpoint is low because single endpoints require large samples due to their low incidence. The current study sought...
8.
Lu J, Wang F, Zhang W, Ren Y, Yang T, Ratti F, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2499-2500.
PMID: 39863801
No abstract available.
9.
Altaf A, Khalil M, Akabane M, Rashid Z, Kawashima J, Zindani S, et al.
Eur J Surg Oncol
. 2025 Jan;
51(5):109594.
PMID: 39826445
Objective: We sought to develop a predictive model to preoperatively identify patients with hepatocellular carcinoma (HCC) at risk of undergoing futile upfront liver resection (LR). Methods: Patients undergoing curative-intent LR...
10.
Altaf A, Munir M, Khan M, Rashid Z, Khalil M, Guglielmi A, et al.
HPB (Oxford)
. 2025 Jan;
PMID: 39753458
Objective: We sought to develop a machine learning (ML) preoperative model to predict bile leak following hepatectomy for primary and secondary liver cancer. Methods: An eXtreme Gradient Boosting (XGBoost) model...